The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
New prognostic factors and scoring system for patients with skeletal metastasis
Open accessAbstract
The aim of this study was to update a previous scoring system for patients with skeletal metastases, that was proposed by Katagiri et al. in 2005, by introducing a new factor (laboratory data) and analyzing a new patient cohort. Between January 2005 and January 2008, we treated 808 patients with symptomatic skeletal metastases. They were prospectively registered regardless of their treatments, and the last follow‐up evaluation was performed in 2012. There were 441 male and 367 female patients with a median age of 64 years. Of these patients, 749 were treated nonsurgically while the remaining 59 underwent surgery for skeletal metastasis. A multivariate analysis was conducted using the Cox proportional hazards model. We identified six significant prognostic factors for survival, namely, the primary lesion, visceral or cerebral metastases, abnormal laboratory data, poor performance status, previous chemotherapy, and multiple skeletal metastases. The first three factors had a larger impact than the remaining three. The prognostic score was calculated by adding together all the scores for individual factors. With a prognostic score of ≥7, the survival rate was 27% at 6 months, and only 6% at 1 year. In contrast, patients with a prognostic score of ≤3 had a survival rate of 91% at 1 year, and 78% at 2 years. Comparing the revised system with the previous one, there was a significantly lower number of wrongly predicted patients using the revised system. This revised scoring system was able to predict the survival rates of patients with skeletal metastases more accurately than the previous system and may be useful for selecting an optimal treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lynch, T. J., Bell, D. W., Sordella, R., Gurubhagavatula, S., Okimoto, R. A., Brannigan, B. W., Harris, P. L., Haserlat, S. M., Supko, J. G., Haluska, F. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040938 · Cited by 11,486
Transection of the oesophagus for bleeding oesophageal varices
Pugh, R. N. H., Murray-Lyon, I. M., Dawson, J. L., Pietroni, M. C., & Williams, R. (1973) · Journal of British Surgery · doi:10.1002/bjs.1800600817 · Cited by 7,941
Harrison's principles of internal medicine
(2008) · Choice Reviews Online · doi:10.5860/choice.46-0330 · Cited by 3,083
Frankel, H. L., Hancock, D. O., Hyslop, G., Melzak, J., Michaelis, L. S., Ungar, G. H., Vernon, J. D. S., & Walsh, J. J. (1969) · Spinal Cord · doi:10.1038/sc.1969.30 · Cited by 2,273
Surgical Strategy for Spinal Metastases
Tomita, K., Kawahara, N., Kobayashi, T., Yoshida, A., Murakami, H., & Akamaru, T. (2001) · Spine · doi:10.1097/00007632-200102010-00016 · Cited by 1,404
A Revised Scoring System for Preoperative Evaluation of Metastatic Spine Tumor Prognosis
Tokuhashi, Y., Matsuzaki, H., Oda, H., Oshima, M., & Ryu, J. (2005) · Spine · doi:10.1097/01.brs.0000180401.06919.a5 · Cited by 1,186
Lipton, A., Fizazi, K., Stopeck, A. T., Henry, D. H., Brown, J. E., Yardley, D. A., Richardson, G. E., Siena, S., Maroto, P., Clemens, M., et al. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.08.002 · Cited by 588
van der Linden, Y. M., Dijkstra, S. P. D. S., Vonk, E. J. A., Marijnen, C. A. M., Leer, J. W. H., & for The Dutch Bone Metastasis Study Group (2005) · Cancer · doi:10.1002/cncr.20756 · Cited by 396
Evaluation of Five Radiation Schedules and Prognostic Factors for Metastatic Spinal Cord Compression
Rades, D., Stalpers, L. J. A., Veninga, T., Schulte, R., Hoskin, P. J., Obralic, N., Bajrovic, A., Rudat, V., Schwarz, R., Hulshof, M. C., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.754 · Cited by 347
Predictors of Survival in Patients With Bone Metastasis of Lung Cancer
Sugiura, H., Yamada, K., Sugiura, T., Hida, T., & Mitsudomi, T. (2008) · Clinical Orthopaedics & Related Research · doi:10.1007/s11999-007-0051-0 · Cited by 280
Prognostic factors and a scoring system for patients with skeletal metastasis
Katagiri, H., Takahashi, M., Wakai, K., Sugiura, H., Kataoka, T., & Nakanishi, K. (2005) · The Journal of Bone and Joint Surgery. British volume · doi:10.1302/0301-620x.87b5.15185 · Cited by 279
Self-citationMetastatic renal carcinoma comprehensive prognostic system
and DGCIN - German Cooperative Renal Carcinoma Chemo-Immunotherapy Trials Group, Atzpodien, J., Royston, P., Wandert, T., & Reitz, M. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600768 · Cited by 241
Predictive markers in breast cancer – the present
Payne, S. J. L., Bowen, R. L., Jones, J. L., & Wells, C. A. (2008) · Histopathology · doi:10.1111/j.1365-2559.2007.02897.x · Cited by 229
van der Linden, Y. M., Steenland, E., van Houwelingen, H. C., Post, W. J., Oei, B., Marijnen, C. A. M., & Leer, J. W. H. (2006) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2006.02.007 · Cited by 183
Prognostic Role of C-Reactive Protein in Breast Cancer: A Systematic Review and Meta-Analysis
Han, Y., Mao, F., Wu, Y., Fu, X., Zhang, W., Zhu, X., Zhou, S., Zhang, W., Sun, Q., & Zhao, Y. (2011) · The International Journal of Biological Markers · doi:10.5301/jbm.2011.8872 · Cited by 106
Chemotherapy for androgen-independent prostate cancer
Petrylak, D. P. (2002) · Seminars in Urologic Oncology · doi:10.1053/suro.2002.35052 · Cited by 62
Metadata
- Authors
- Katagiri, H., Okada, R., Takagi, T., Takahashi, M., Murata, H., Harada, H., Nishimura, T., Asakura, H., & Ogawa, H.
- Venue
- Cancer Medicine
- Publisher
- Wiley
- Published
- 2014-07-10
- Volume
- 3
- Issue
- 5
- Pages
- 1359-1367
- ISSN
- 2045-7634 (ISSN-L)
- OpenAlex
- W2028654075
- Cited by
- 421
- References
- 16
- FWCI
- 10.16
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.